Biochemical markers: Summary
- 1 September 2002
- journal article
- research article
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis
- Vol. 3 (2) , S85-S90
- https://doi.org/10.1080/146608202320374408
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patientsActa Neurologica Scandinavica, 2009
- p53 Is Abnormally Elevated and Active in the CNS of Patients with Amyotrophic Lateral SclerosisNeurobiology of Disease, 2000
- Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS)Acta Neurologica Scandinavica, 1999
- Presence of 4‐hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosisAnnals of Neurology, 1998
- Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSFJournal of Neurochemistry, 1996
- Spinal Fluid Cells and Protein in Amyotrophic Lateral SclerosisArchives of Neurology, 1993
- A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Clinical correlations of Anti-Gm1 antibodies in amyotrophic lateral sclerosis and neuropathiesMuscle & Nerve, 1991
- Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's diseaseNeuroscience Letters, 1990